Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.60
-0.13-7.25%
At close: -
$1.60
0.000.00%
After Hours: 4:50 PM EDT
Comments
Loading...
ModivCare Analyst Ratings and Price Targets | NASDAQ:MODV | Benzinga
ModivCare Inc has a consensus price target of $28.08 based on the ratings of 6 analysts. The high is $95 issued by Stephens & Co. on June 27, 2023. The low is $3.5 issued by Stephens & Co. on March 10, 2025. The 3 most-recent analyst ratings were released by Stephens & Co., Barrington Research, and Barrington Research on March 10, 2025, March 7, 2025, and January 14, 2025, respectively. With an average price target of $6.5 between Stephens & Co., Barrington Research, and Barrington Research, there's an implied 306.25% upside for ModivCare Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stephens & Co.
Barrington Research
Lake Street
Jefferies
Deutsche Bank
1calculated from analyst ratings
Analyst Ratings for ModivCare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/10/2025 | Buy Now | 118.75% | Stephens & Co. | Raj Kumar 38% | $7 → $3.5 | Maintains | Equal-Weight | Get Alert |
| 03/07/2025 | Buy Now | 275% | Barrington Research | Michael Petusky52% | $10 → $6 | Maintains | Outperform | Get Alert |
| 01/14/2025 | Buy Now | 525% | Barrington Research | Michael Petusky52% | $25 → $10 | Maintains | Outperform | Get Alert |
| 01/13/2025 | Buy Now | 525% | Lake Street | Brooks O'Neil37% | $30 → $10 | Maintains | Buy | Get Alert |
| 01/10/2025 | Buy Now | 962.5% | Stephens & Co. | Raj Kumar 38% | $21 → $17 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/18/2024 | Buy Now | 1462.5% | Barrington Research | Michael Petusky52% | $25 → $25 | Maintains | Outperform | Get Alert |
| 11/08/2024 | Buy Now | 1462.5% | Barrington Research | Michael Petusky52% | $22 → $25 | Maintains | Outperform | Get Alert |
| 10/03/2024 | Buy Now | 1275% | Barrington Research | Michael Petusky52% | $19 → $22 | Maintains | Outperform | Get Alert |
| 09/17/2024 | Buy Now | 1087.5% | Barrington Research | Michael Petusky52% | $35 → $19 | Maintains | Outperform | Get Alert |
| 09/17/2024 | Buy Now | 1775% | Lake Street | Brooks O'Neil37% | $50 → $30 | Maintains | Buy | Get Alert |
| 09/13/2024 | Buy Now | 775% | Jefferies | Brian Tanquilut45% | $25 → $14 | Maintains | Hold | Get Alert |
| 08/09/2024 | Buy Now | 2087.5% | Barrington Research | Michael Petusky52% | → $35 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/06/2024 | Buy Now | 3025% | Lake Street | Brooks O'Neil37% | → $50 | Upgrade | Hold → Buy | Get Alert |
| 02/26/2024 | Buy Now | — | Barrington Research | Michael Petusky52% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/23/2024 | Buy Now | 2337.5% | Jefferies | Brian Tanquilut45% | $60 → $39 | Downgrade | Buy → Hold | Get Alert |
| 02/23/2024 | Buy Now | 2400% | Deutsche Bank | Pito Chickering67% | $60 → $40 | Downgrade | Buy → Hold | Get Alert |
| 11/06/2023 | Buy Now | 4150% | Barrington Research | Michael Petusky52% | $58 → $68 | Maintains | Outperform | Get Alert |
| 08/07/2023 | Buy Now | 3525% | Barrington Research | Michael Petusky52% | $92 → $58 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2023 | Buy Now | 3025% | Deutsche Bank | Pito Chickering67% | $75 → $50 | Maintains | Buy | Get Alert |
| 06/27/2023 | Buy Now | 5837.5% | Stephens & Co. | Scott Fidel68% | → $95 | Reiterates | Overweight → Overweight | Get Alert |
| 06/06/2023 | Buy Now | 5837.5% | Stephens & Co. | Scott Fidel68% | → $95 | Reiterates | Overweight → Overweight | Get Alert |
| 05/05/2023 | Buy Now | 5650% | Barrington Research | Michael Petusky52% | $143 → $92 | Maintains | Outperform | Get Alert |
| 05/05/2023 | Buy Now | 5837.5% | Stephens & Co. | Scott Fidel68% | $145 → $95 | Maintains | Overweight | Get Alert |
| 02/24/2023 | Buy Now | 7400% | Deutsche Bank | Pito Chickering67% | $100 → $120 | Maintains | Buy | Get Alert |
| 02/24/2023 | Buy Now | 8837.5% | Barrington Research | Michael Petusky52% | $138 → $143 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | 8525% | Barrington Research | Michael Petusky52% | $157 → $138 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | 8962.5% | Stephens & Co. | Scott Fidel68% | → $145 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for ModivCare (MODV) stock?
The latest price target for ModivCare (NASDAQ:MODV) was reported by Stephens & Co. on March 10, 2025. The analyst firm set a price target for $3.50 expecting MODV to rise to within 12 months (a possible 118.75% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ModivCare (MODV)?
The latest analyst rating for ModivCare (NASDAQ:MODV) was provided by Stephens & Co., and ModivCare maintained their equal-weight rating.
When was the last upgrade for ModivCare (MODV)?
The last upgrade for ModivCare Inc happened on August 9, 2024 when Barrington Research raised their price target to $35. Barrington Research previously had a market perform for ModivCare Inc.
When was the last downgrade for ModivCare (MODV)?
The last downgrade for ModivCare Inc happened on January 10, 2025 when Stephens & Co. changed their price target from $21 to $17 for ModivCare Inc.
When is the next analyst rating going to be posted or updated for ModivCare (MODV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ModivCare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ModivCare was filed on March 10, 2025 so you should expect the next rating to be made available sometime around March 10, 2026.
Is the Analyst Rating ModivCare (MODV) correct?
While ratings are subjective and will change, the latest ModivCare (MODV) rating was a maintained with a price target of $7.00 to $3.50. The current price ModivCare (MODV) is trading at is $1.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.